In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Abbott splits, spins off AbbVie

Executive Summary

As of January 1, 2013, Abbott Laboratories Inc. will split into two separate, publicly traded health care companies by spinning off AbbVie Inc. Abbott will focus on diversified medical products--nutritionals (28%), devices (27%), generics (25%), and diagnostics (20%)--and AbbVie will become a research-based pharmaceutical firm that sells pharmaceuticals and biologics in the US and worldwide.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Divestiture/Spin-Out

Related Companies